Livzon Pharmaceutical Group Inc 2018 SR
The report highlights Livzon Pharmaceutical Group's 2018 ESG performance, focusing on innovation in R&D, operation compliance, and social responsibility. The company invested RMB 687.24 million in R&D, a 19.42% increase, and received multiple industry awards for its research strengths. Livzon emphasized Targeted Poverty Alleviation through its Huangqi industry model and donated over RMB 3.9 million to charitable causes. Environmental efforts included reducing greenhouse gas emission intensity to 0.5 tonnes of CO2e per RMB 10,000 of operating income. The group also maintained a strong focus on product quality, with 31 production lines passing GMP certification.
Company: Livzon Pharmaceutical Group Inc
Sector: Manufacturing
Country: China
Year: 2018
Type: SR
Pages: 72
Back to company
Livzon Pharmaceutical Group Inc
ESG Report
The report highlights Livzon Pharmaceutical Group's 2018 ESG performance, focusing on innovation in R&D, operation compliance, and social responsibility. The company invested RMB 687.24 million in R&D, a 19.42% increase, and received multiple industry awards for its research strengths. Livzon emphasized Targeted Poverty Alleviation through its Huangqi industry model and donated over RMB 3.9 million to charitable causes. Environmental efforts included reducing greenhouse gas emission intensity to 0.5 tonnes of CO2e per RMB 10,000 of operating income. The group also maintained a strong focus on product quality, with 31 production lines passing GMP certification.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Employees